UBS analyst Joshua Chan raised the firm’s price target on Aramark (ARMK) to $48 from $47 and keeps a Buy rating on the shares. With several potential catalysts over the coming months, the firm likes the near-term setup for Aramark into fiscal Q2, the analyst tells investors in a preview.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARMK: